News

Human Genome Sciences (HGS) designed the phase III program in collaboration with GlaxoSmithKline and leading international systemic lupus erythematosus (SLE) experts, and expects to initiate phase III trials

Financial terms were not disclosed, but the companies revealed that, under the terms of the agreement, Genizon will receive an upfront payment, research funding and milestone payments for

Zolpidem is the active ingredient found in the number one selling hypnotic, Ambien (zolpidem tartrate), which is marketed by Sanofi-Aventis. The trial, which is being conducted in healthy

AE37 is a novel immunotherapeutic vaccine being developed by Generex’ wholly owned subsidiary Antigen Express. The compound has been in clinical trials for more than a year at

The phase III trial will evaluate approximately 300 previously-treated patients with locally advanced and/or metastatic pancreatic cancer who receive best supportive care (BSC) or glufosfamide once every three

Maryland-based In Vitro Technologies (IVT) supplies products and services to improve the drug discovery and development process. The company’s product portfolio includes proprietary ADME-Tox products, including fresh and

While the terms of the license have not been disclosed, Potentia has announced that this agreement will allow the company to move forward with the preclinical development of

Halozyme’s Enhanze Technology is based on recombinant human PH20 hyaluronidase (rHuPH20). This current clinical trial is designed to compare the pharmacokinetics, safety and tolerability of a large molecule

The Montreal-based company reported in July that a death had occurred in the trial at a clinical site in Argentina. The trial was an international multi-center, randomized, placebo-controlled,